Kindly MD, Inc. (NAKA)
NASDAQ: NAKA · Real-Time Price · USD
0.8832
-0.0545 (-5.81%)
Oct 10, 2025, 12:55 PM EDT - Market open
Kindly MD Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Kindly MD stock has a target of 8.00, which predicts a 805.80% increase from the current stock price of 0.88.
Price Target: $8.00 (+805.80%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 3, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Kindly MD is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +805.80% | Sep 3, 2025 |
Financial Forecast
Revenue This Year
1.83M
from 2.72M
Decreased by -32.90%
Revenue Next Year
102.87M
from 1.83M
Increased by 5,536.71%
EPS This Year
-0.06
from -0.67
EPS Next Year
n/a
from -0.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.9M | 105.9M | |
| Avg | 1.8M | 102.9M | |
| Low | 1.8M | 98.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -31.0% | 5,702.2% | |
| Avg | -32.9% | 5,536.7% | |
| Low | -35.5% | 5,315.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.06 | - | |
| Avg | -0.06 | - | |
| Low | -0.06 | - |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.